Skip to main content

#Influenza and Other Respiratory Viruses Research #References (by AMEDEO, February 1 '25)

Image
By G.M.

 


    Biochemistry (Mosc)

  1. KOROLEVA ON, Kuzmina NV, Tolstova AP, Dubrovin EV, et al
    Effect of C- and N-Terminal Polyhistidine Tags on Aggregation of Influenza A Virus Nuclear Export Protein.
    Biochemistry (Mosc). 2024;89:2238-2251.
    PubMed         Abstract available


    BMC Pediatr

  2. ZHANG P, Xin M, Bai Y, Ren X, et al
    Severe central nervous system injury in 9 children with COVID-19.
    BMC Pediatr. 2025;25:63.
    PubMed         Abstract available


    Epidemiol Infect

  3. BEDNARSKA NG, Smith S, Bardsley M, Loveridge P, et al
    Trends in general practitioner consultations for hand foot and mouth disease in England between 2017 and 2022.
    Epidemiol Infect. 2025;153:e22.
    PubMed         Abstract available


    J Virol

  4. KIRKPATRICK ROUBIDOUX E, Meliopoulos V, Livingston B, Brigleb PH, et al
    Intraductal infection with H5N1 clade 2.3.4.4b influenza virus.
    J Virol. 2025 Jan 31:e0192724. doi: 10.1128/jvi.01927.
    PubMed        

  5. SADLER HL, Rijal P, Tan TK, Townsend ARM, et al
    A locally administered single-cycle influenza vaccine expressing a non-fusogenic stabilized hemagglutinin stimulates strong T-cell and neutralizing antibody immunity.
    J Virol. 2025 Jan 27:e0033124. doi: 10.1128/jvi.00331.
    PubMed         Abstract available

  6. ZHAO B, Sun Z, Wang S, Shi Z, et al
    Structural basis of different neutralization capabilities of monoclonal antibodies against H7N9 virus.
    J Virol. 2025;99:e0140024.
    PubMed         Abstract available

  7. CAI Z, Ni W, Li W, Wu Z, et al
    SARS-CoV-2 S protein disrupts the formation of ISGF3 complex through conserved S2 subunit to antagonize type I interferon response.
    J Virol. 2024 Dec 19:e0151624. doi: 10.1128/jvi.01516.
    PubMed         Abstract available

  8. KAKIZAKI M, Hashimoto R, Nagata N, Yamamoto T, et al
    The respective roles of TMPRSS2 and cathepsins for SARS-CoV-2 infection in human respiratory organoids.
    J Virol. 2024 Nov 27:e0185324. doi: 10.1128/jvi.01853.
    PubMed         Abstract available

  9. BOLLAND W, Marechal I, Petiot C, Porrot F, et al
    SARS-CoV-2 entry and fusion are independent of ACE2 localization to lipid rafts.
    J Virol. 2024 Nov 21:e0182324. doi: 10.1128/jvi.01823.
    PubMed         Abstract available


    JAMA

  10. BOCK A
    CDC Advises Expedited Influenza Subtyping in Hospitalized Patients to Help Identify Bird Flu Cases Sooner.
    JAMA. 2025 Jan 31. doi: 10.1001/jama.2025.0679.
    PubMed        


    Lancet

  11. MUMFORD L, Hogg R, Taylor A, Lanyon P, et al
    Impact of SARS-CoV-2 spike antibody positivity on infection and hospitalisation rates in immunosuppressed populations during the omicron period: the MELODY study.
    Lancet. 2025;405:314-328.
    PubMed         Abstract available


    PLoS Biol

  12. MEARS HV, Young GR, Sanderson T, Harvey R, et al
    Emergence of SARS-CoV-2 subgenomic RNAs that enhance viral fitness and immune evasion.
    PLoS Biol. 2025;23:e3002982.
    PubMed         Abstract available


    PLoS One

  13. KUMOSANI TA, Abbas AT, Basheer B, Hassan AM, et al
    Investigating Pb2 CAP-binding domain inhibitors from marine bacteria for targeting the influenza A H5N1.
    PLoS One. 2025;20:e0310836.
    PubMed         Abstract available

  14. TAT VY, Drelich AK, Huang P, Khanipov K, et al
    Characterizing temporal and global host innate immune responses against SARS-CoV-1 and -2 infection in pathologically relevant human lung epithelial cells.
    PLoS One. 2025;20:e0317921.
    PubMed         Abstract available

  15. BIDHENDI-YARANDI R, Biglarian A, Karlstad JL, Moe CF, et al
    Prevalence of depression, anxiety, stress, and suicide tendency among individual with long-COVID and determinants: A systematic review and meta-analysis.
    PLoS One. 2025;20:e0312351.
    PubMed         Abstract available

  16. CLANCY P, Cassarino M
    Burnout and organisational stressors among healthcare staff working with adults with intellectual disabilities in Ireland.
    PLoS One. 2025;20:e0313767.
    PubMed         Abstract available

  17. HEGAZI MA, Sayed MH, Butt NS, Alahmadi TS, et al
    Navigating the shots: Parental willingness to immunize their children with COVID-19 vaccines in Saudi Arabia explored through a systematic review and meta-analysis.
    PLoS One. 2025;20:e0317983.
    PubMed         Abstract available

  18. YIN J, Xu J
    Intellectual capital, digital transformation and firms' financial performance: Evidence from ecological protection and environmental governance industry in China.
    PLoS One. 2025;20:e0316724.
    PubMed         Abstract available

  19. SUCHANEK P, Bucicova N
    The customer satisfaction model in the mobile telecommunications sector after Covid-19 pandemic.
    PLoS One. 2025;20:e0317093.
    PubMed         Abstract available

  20. MORBEY RA, Todkill D, Moura P, Tollinton L, et al
    Using machine learning to forecast peak health care service demand in real-time during the 2022-23 winter season: A pilot in England, UK.
    PLoS One. 2025;20:e0292829.
    PubMed         Abstract available

  21. LIU H, Zhao M, She C, Peng H, et al
    Classification of CT scan and X-ray dataset based on deep learning and particle swarm optimization.
    PLoS One. 2025;20:e0317450.
    PubMed         Abstract available

  22. GOPALAN N, Viswanathan VK, Srinivasalu VA, Arumugam S, et al
    Prediction of mortality and prioritisation to tertiary care using the 'OUR-ARCad' risk score gleaned from the second wave of COVID-19 pandemic-A retrospective cohort study from South India.
    PLoS One. 2025;20:e0312993.
    PubMed         Abstract available

  23. LEE I, Park H
    Moderating role of age in the relationship between ingroup range and intention to help during the COVID-19 pandemic.
    PLoS One. 2025;20:e0316316.
    PubMed         Abstract available

  24. SOLANKI G, Cleary S, Little F
    Impact of COVID-19 vaccination on hospitalization, hospital utilization and expenditure for COVID-19: A retrospective cohort analysis of a South African private health insured population.
    PLoS One. 2025;20:e0317686.
    PubMed         Abstract available

  25. MOHARRAM FA, Ibrahim RR, Mahgoub S, Abdel-Aziz MS, et al
    Secondary metabolites of Alternaria alternate appraisal of their SARS-CoV-2 inhibitory and anti-inflammatory potentials.
    PLoS One. 2025;20:e0313616.
    PubMed         Abstract available

  26. BIOTTI F, Barker M, Carr L, Pickard H, et al
    The effects of the SARS-CoV-2 pandemic on self-reported interoception and mental health.
    PLoS One. 2025;20:e0314272.
    PubMed         Abstract available

  27. TOBITA Y, Diagne M, Bassama J, Ndong M, et al
    Exploring shifts in values among urban Senegalese: The impact of global crises on social and cultural norms.
    PLoS One. 2025;20:e0316162.
    PubMed         Abstract available

  28. AUDIGE A, Amstutz A, Schuurmans MM, Amico P, et al
    Low agreement and frequent invalid controls in two SARS-CoV-2 T-cell assays in people with compromised immune function.
    PLoS One. 2025;20:e0317965.
    PubMed         Abstract available

  29. ROMANO ME, Buckley JP, Li X, Herbstman JB, et al
    Changes in urinary concentrations of contemporary and emerging chemicals in commerce during the COVID-19 pandemic: Insights from the Environmental influences on Child Health Outcomes (ECHO) program.
    PLoS One. 2025;20:e0317358.
    PubMed         Abstract available

  30. WEN Z, Wang T, Luo S, Liu Y, et al
    CT scan-derived pectoralis muscle parameters are closely associated with COVID-19 outcomes: A systematic review and meta-analysis.
    PLoS One. 2025;20:e0316893.
    PubMed         Abstract available

  31. BOS I, Bosman L, van den Hoek R, van Waarden W, et al
    Comparison of observational methods to identify and characterize post-COVID syndrome in the Netherlands using electronic health records and questionnaires.
    PLoS One. 2025;20:e0318272.
    PubMed         Abstract available

  32. SANTACROCE LA, Appiah R, Sullivan MD, Spaniol J, et al
    Brief social presence improves delayed memory for online lecture content.
    PLoS One. 2025;20:e0318149.
    PubMed         Abstract available

  33. RO G, Lyngstad TM, Seppala E, Naerland Skodvin S, et al
    Estimating the trend of COVID-19 in Norway by combining multiple surveillance indicators.
    PLoS One. 2025;20:e0317105.
    PubMed         Abstract available

  34. RAZAI MS, Ussher M, Goldsmith L, Hargreaves S, et al
    Navigating vaccination in pregnancy: Qualitative study in 21 ethnically diverse pregnant women.
    PLoS One. 2025;20:e0310823.
    PubMed         Abstract available

  35. BONSAKSEN T, Price D, Lamph G, Kabelenga I, et al
    Sleep problems were unrelated to social media use in the late COVID-19 pandemic phase: A cross-national study.
    PLoS One. 2025;20:e0318507.
    PubMed         Abstract available

  36. WANG W, Zhu W, Hajagos J, Fochtmann L, et al
    Classification and Regression Trees analysis identifies patients at high risk for kidney function decline following hospitalization.
    PLoS One. 2025;20:e0317558.
    PubMed         Abstract available

  37. KYALA NJ, Mboya I, Shao E, Sakita F, et al
    Neutrophil-to-lymphocyte ratio as a prognostic indicator in COVID-19: Evidence from a northern tanzanian cohort.
    PLoS One. 2025;20:e0300231.
    PubMed         Abstract available


    Proc Natl Acad Sci U S A

  38. NAKAMURA S, Tanimura Y, Nomura R, Suzuki H, et al
    Structure-guided engineering of a mutation-tolerant inhibitor peptide against variable SARS-CoV-2 spikes.
    Proc Natl Acad Sci U S A. 2025;122:e2413465122.
    PubMed         Abstract available

  39. YAN S, Schlick T
    Heterogeneous and multiple conformational transition pathways between pseudoknots of the SARS-CoV-2 frameshift element.
    Proc Natl Acad Sci U S A. 2025;122:e2417479122.
    PubMed         Abstract available


    Vaccine

  40. LE N, McMann TJ, Wenzel C, Li Z, et al
    COVID-19 pediatric vaccine Hesitancy: Themes and interactions with verified twitter accounts.
    Vaccine. 2025;47:126688.
    PubMed         Abstract available

  41. CASPERSEN IH, Skodvin SN, Blix K, Robertson AH, et al
    Post-COVID symptoms after SARS-CoV-2 omicron infection and the effect of booster vaccination: A population-based cohort study.
    Vaccine. 2025;47:126664.
    PubMed         Abstract available

  42. SHIELDS T, King KD, Cripps S, Edwards SA, et al
    Perspectives on vaccination among unvaccinated members of a Canadian indigenous population.
    Vaccine. 2025;47:126665.
    PubMed         Abstract available

  43. COROMINAS J, Garriga C, Prenafeta A, Moros A, et al
    Humoral and cellular immune responses after 6 months of a heterologous SARS-CoV-2 booster with the protein-based PHH-1V vaccine in a phase IIb trial.
    Vaccine. 2025;47:126685.
    PubMed         Abstract available

  44. CLAESSENS T, Eagan RL, Hendrickx G, Van Damme P, et al
    Navigating vaccine confidence: A mixed methods study investigating healthcare providers' perspectives across four non-EU European regions.
    Vaccine. 2025;47:126694.
    PubMed         Abstract available

  45. KHAN A, Zhu Y, Babcock HM, Busse LW, et al
    COVID-19 and influenza vaccine Hesitancy among adults hospitalized in the United States, 2019-2022.
    Vaccine. 2025 Jan 29:126806. doi: 10.1016/j.vaccine.2025.126806.
    PubMed         Abstract available

  46. KEMP M, Capriola A, Schauer S
    RSV immunization uptake among infants and pregnant persons - Wisconsin, October 1, 2023-March 31, 2024.
    Vaccine. 2025;47:126674.
    PubMed         Abstract available

  47. DUAN Y, Suo L, Li X, Bai C, et al
    Association between underlying conditions, multimorbidity, and COVID-19 vaccination status of adults aged >/=80 years old in Beijing, China.
    Vaccine. 2025;47:126677.
    PubMed         Abstract available
Labels:

Comments

Post a Comment

Popular posts from this blog

#Neuroinvasive #Oropouche virus in a patient with #HIV from extra-Amazonian #Brazil

By G.M.
{Excerpt} A novel reassortant Oropouche virus (OROV) lineage (with medium [M], large [L], and small [S] RNA segments : M1L2S2) has driven Brazil's largest and most geographically widespread OROV epidemic , expanding beyond the endemic Amazon basin to establish local transmission across multiple Brazilian states and other previously unaffected Latin American countries . The rapid spread of this lineage underscores its evolutionary potential and reinforces its significance as a public health threat .1 Similar to chikungunya and Zika viruses, expanding arboviruses can exhibit unexpected clinical and epidemiological shifts , including vertical transmissions , neuroinvasive effects, and potentially fatal outcomes.2–4 Although OROV typically causes self-limited febrile illness, accumulating clinical and experimental evidence suggests neurotropic potential .5 This Correspondence describes the first confirmed case of neuroinvasive OROV infection caused by the emergent M1L2S2 lineage in ext...
Post a Comment
Read more »

Stability of #influenza viruses in the #milk of #cows and #sheep

By G.M.
Abstract In late 2023, H5N1 high pathogenicity avian influenza (HPAIV) started circulating in dairy cattle in the USA . High viral titres were detected in milk from infected cows , raising concerns about onwards human infections . Although pasteurisation was shown to effectively inactivate influenza viruses in milk, unpasteurised milk still poses a risk of infection, both from occupational exposure in dairies and from the consumption of raw milk. We therefore assessed how long influenza viruses could remain infectious for in milk without heat inactivation. We examined the stability of a panel of influenza viruses in milk , including a contemporary H5N1 HPAIV and a variety of other influenza A and D viruses. We incubated viruses in cows' milk under laboratory conditions : at room temperature to simulate exposure in dairies and at 4°C to simulate exposure to refrigerated raw milk. Following an isolated report of H5N1 viral RNA being detected in milk from a sheep in the UK , we also c...
Post a Comment
Read more »

#Evidence of #Viremia in Dairy #Cows Naturally Infected with #Influenza A {#H5N1} Virus, #California, #USA

By G.M.
Abstract We confirmed influenza A virus (IAV) by PCR in serum from 18 cows on 3 affected dairy farms in California, USA . Our findings indicate the presence of viremia and might help explain IAV transmission dynamics and shedding patterns in cows. An understanding of those dynamics could enable development of IAV mitigation strategies. Source: US Centers for Disease Control and Prevention,  https://wwwnc.cdc.gov/eid/article/31/7/25-0134_article ____
Post a Comment
Read more »